| Dr Benjamin James Turnbow, MD | |
|
4121 W Highway 98, Panama City, FL 32401-1170 | |
| (850) 914-7060 | |
| (850) 914-7065 |
| Full Name | Dr Benjamin James Turnbow |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 17 Years |
| Location | 4121 W Highway 98, Panama City, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386835577 | NPI | - | NPPES |
| 4641596099 | Other | MYUTMB 4641596099 |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sacred Heart Hospital | Pensacola, FL | Hospital |
| D W Mcmillan Memorial Hospital | Brewton, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sacred Heart Health System Inc | 3779491386 | 355 |
News Archive
NeuroTherapeutics Pharma, Inc. (NTP), a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders, announced today that it closed a $43 million Series B financing. New investors include Fidelity Biosciences, MPM Capital and SR One, who co-led the transaction, and Pfizer, Inc. Existing investors Novo Ventures and Thomas McNerney & Partners also participated in the round.
The American Philosophical Society (APS) has awarded New York University neuroscientist J. Anthony Movshon its 2013 Karl Spencer Lashley Award in recognition of his "pioneering work on the neuroscience of vision."
Shiseido Co., Ltd. announces plans to open the Shiseido Cell-Processing and Expansion Center (SPEC) on May 1, 2014. The center, located in the in the Kobe Biomedical Innovation Cluster in Kobe, Japan, will centralize research and development on hair regenerative medicine with an aim toward commercialization.
Transave Inc. today announced that the United States Patent and Trademark Office has issued an important composition of matter patent (U.S. Patent No. 7,718,189) for liposomal aminoglycoside formulations including its lead compound, ARIKACE™ (liposomal amikacin for inhalation). The company expects that the patent will provide exclusivity for ARIKACE until October 1, 2026.
Researchers at the University of Texas Medical Branch at Galveston have discovered a way to block a disease pathway that could be a breakthrough in defeating some of the world's most devastating human infections.
› Verified 3 days ago
| Entity Name | Sacred Heart Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962453308 PECOS PAC ID: 3779491386 Enrollment ID: O20051015000049 |
News Archive
NeuroTherapeutics Pharma, Inc. (NTP), a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders, announced today that it closed a $43 million Series B financing. New investors include Fidelity Biosciences, MPM Capital and SR One, who co-led the transaction, and Pfizer, Inc. Existing investors Novo Ventures and Thomas McNerney & Partners also participated in the round.
The American Philosophical Society (APS) has awarded New York University neuroscientist J. Anthony Movshon its 2013 Karl Spencer Lashley Award in recognition of his "pioneering work on the neuroscience of vision."
Shiseido Co., Ltd. announces plans to open the Shiseido Cell-Processing and Expansion Center (SPEC) on May 1, 2014. The center, located in the in the Kobe Biomedical Innovation Cluster in Kobe, Japan, will centralize research and development on hair regenerative medicine with an aim toward commercialization.
Transave Inc. today announced that the United States Patent and Trademark Office has issued an important composition of matter patent (U.S. Patent No. 7,718,189) for liposomal aminoglycoside formulations including its lead compound, ARIKACE™ (liposomal amikacin for inhalation). The company expects that the patent will provide exclusivity for ARIKACE until October 1, 2026.
Researchers at the University of Texas Medical Branch at Galveston have discovered a way to block a disease pathway that could be a breakthrough in defeating some of the world's most devastating human infections.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Benjamin James Turnbow, MD 4205 Belfort Rd Ste 4015, Jacksonville, FL 32216-3623 Ph: (904) 450-6014 | Dr Benjamin James Turnbow, MD 4121 W Highway 98, Panama City, FL 32401-1170 Ph: (850) 914-7060 |
News Archive
NeuroTherapeutics Pharma, Inc. (NTP), a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders, announced today that it closed a $43 million Series B financing. New investors include Fidelity Biosciences, MPM Capital and SR One, who co-led the transaction, and Pfizer, Inc. Existing investors Novo Ventures and Thomas McNerney & Partners also participated in the round.
The American Philosophical Society (APS) has awarded New York University neuroscientist J. Anthony Movshon its 2013 Karl Spencer Lashley Award in recognition of his "pioneering work on the neuroscience of vision."
Shiseido Co., Ltd. announces plans to open the Shiseido Cell-Processing and Expansion Center (SPEC) on May 1, 2014. The center, located in the in the Kobe Biomedical Innovation Cluster in Kobe, Japan, will centralize research and development on hair regenerative medicine with an aim toward commercialization.
Transave Inc. today announced that the United States Patent and Trademark Office has issued an important composition of matter patent (U.S. Patent No. 7,718,189) for liposomal aminoglycoside formulations including its lead compound, ARIKACE™ (liposomal amikacin for inhalation). The company expects that the patent will provide exclusivity for ARIKACE until October 1, 2026.
Researchers at the University of Texas Medical Branch at Galveston have discovered a way to block a disease pathway that could be a breakthrough in defeating some of the world's most devastating human infections.
› Verified 3 days ago
John R Cotton, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1827 Harrison Ave, Panama City, FL 32405 Phone: 850-785-4344 Fax: 850-785-0842 | |
Joseph Patrick Grace, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1827 Harrison Ave, Panama City, FL 32405 Phone: 850-769-3574 Fax: 850-763-7979 | |
Daniel Drake Satterfield, PA Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1827 Harrison Ave, Panama City, FL 32405 Phone: 850-785-4344 | |
Dr. Mark Ngu Awantang, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1827 Harrison Ave, Panama City, FL 32405 Phone: 850-522-4263 Fax: 850-785-9681 | |
Dr. Kevin Patrick O'halloran, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2943 Highway 77, Panama City, FL 32405 Phone: 850-914-7060 Fax: 850-914-7065 | |
Dr. Nicholas W Crossman, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1827 Harrison Ave, Panama City, FL 32405 Phone: 850-785-4344 Fax: 850-763-5456 | |
Cory R Gaiser, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1399 Jenks Ave Bldg G, Panama City, FL 32401 Phone: 850-771-2001 Fax: 850-215-4229 |